@article{9733467f7ad64d69a7c71009c57a0fc7,
title = "Functional deficits in attenuated psychosis syndrome and related conditions: Current and future treatment options",
keywords = "Attenuated psychosis syndrome, Cognitive impairment, Functional capacity, Real-world functioning",
author = "Harvey, {Philip D.} and Jones, {Mackenzie Taylor}",
note = "Funding Information: Funding for writing assistance for this article was provided by Boehringer Ingelheim International GmbH. The sponsor was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. No financial support of any kind was given to the authors. Funding Information: Editorial support in the form of initial preparation of the outline based on input from all authors, and collation and incorporation of author feedback to develop subsequent drafts, assembling tables and figures, copy-editing and referencing was provided by Sam Halliwell, PhD of Fishawack Communications Ltd., which was funded by Boehringer Ingelheim GmbH. Funding Information: PDH has served as a consultant in the past year to Alkermes, Boehringer-Ingelheim, Lundbeck, Otsuka America, Sanofi, Sunovion Pharmaceuticals, Takeda, and Teva, and has received research grants from Takeda and Stanley Medical Research Foundation. MTJ reports no potential biomedical conflicts of interest. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2019",
month = sep,
doi = "10.1016/j.scog.2019.100152",
language = "English (US)",
volume = "17",
journal = "Schizophrenia Research: Cognition",
issn = "2215-0013",
publisher = "Elsevier Inc.",
}